What Does GeneDx Do?

Total employees832
HeadquartersStamford
Founded

GeneDx is a pioneering genomics company dedicated to transforming healthcare through data-driven insights and advanced diagnostic solutions. With a strong legacy in rare disease genetics and an expanding focus on oncology, GeneDx utilizes cutting-edge genomic sequencing technologies and sophisticated data analysis to provide actionable information for clinicians, researchers, and patients. The company's mission is to improve health outcomes by enabling more precise diagnoses, predicting disease risk, and personalizing medical treatments. GeneDx is committed to ongoing scientific innovation, building comprehensive clinico-genomic databases, and collaborating with the global medical community to unravel the complexities of human disease and accelerate medical breakthroughs.

Where Is GeneDx's Headquarters?

HQ Function

Serves as the central hub for GeneDx's corporate governance, strategic planning, finance, legal affairs, investor relations, and overall executive leadership for its national and international operations.

Notable Features:

Modern office facilities within a multi-tenant corporate building, offering amenities designed to support a productive and collaborative workforce. Its location provides excellent connectivity to the New York metropolitan area.

Work Culture:

The Stamford headquarters fosters a dynamic, professional, and mission-driven work environment. It emphasizes strategic thinking, cross-functional collaboration, and a collective commitment to advancing genomic medicine to improve patient lives.

HQ Significance:

The Stamford location anchors GeneDx within a key business and biotech corridor, facilitating access to diverse talent, financial markets, and strategic partnerships essential for its continued growth and leadership in the genomics industry.

Values Reflected in HQ: The choice of a professional, accessible, and strategically positioned headquarters reflects GeneDx's commitment to operational excellence, sustainable growth, and its role as a leading public company dedicated to innovation in genomics.

Location:

While primarily focused on the United States market, GeneDx extends its impact globally by providing advanced genomic testing services for rare diseases and oncology to clinicians and patients in numerous countries. The company's expertise and de-identified data insights are utilized by international healthcare providers and researchers. GeneDx collaborates with international partners and offers services that can be accessed from various parts of the world, contributing to global efforts in diagnosing, understanding, and managing genetic conditions. Comprehensive customer support and scientific consultations are often available to international clients, ensuring broad access to their specialized diagnostic capabilities.

Street Address:

333 Ludlow Street, South Tower

City:

Stamford

State/Province:

Connecticut

Country:

USA

Where Else Does GeneDx Operate Around the World?

Gaithersburg, Maryland, USA

Address: 207 Perry Parkway, Gaithersburg, MD 20877

Serves as a cornerstone for scientific innovation, operational excellence in genetic testing, and data interpretation, supporting clinicians, patients, and research partners across North America and internationally.

Irvine, California, USA

Address: 310 Goddard, Suite 100, Irvine, CA 92618

Enhances GeneDx's national operational footprint, improving capacity for genetic testing services and facilitating engagement with the vibrant life sciences ecosystem on the West Coast.

Buying Intent Signals for GeneDx

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading GeneDx? Meet the Executive Team

As of April 2025, GeneDx' leadership includes:

Katherine Stueland - President and Chief Executive Officer
Kevin Feeley - Chief Financial Officer
Jennifer Brendel - Chief Growth Officer
Melanie Photograph - Chief Operating Officer
Geoff Metcalf - Chief Technology Officer
Paul Krass - Chief Commercial Officer
Karen Kovaleski - Chief People Officer
Emily F. Guzzardi - Chief Counsel
Hannes Smarason - Executive Vice President, Corporate Development and Strategy

Who's Investing in GeneDx?

GeneDx has been backed by several prominent investors over the years, including:

OPKO Health, Inc.
Perceptive Advisors LLC
The Vanguard Group, Inc.
BlackRock Inc.
RA Capital Management, L.P.
Casdin Capital, LLC
Artisan Partners Limited Partnership

What Leadership Changes Has GeneDx Seen Recently?

Hire4
Exits1

Over the past year (May 2023 - May 2024), GeneDx has strategically bolstered its executive leadership with key appointments in growth, operations, technology, and legal functions. These changes reflect the company's ongoing commitment to scaling its genomic platform, driving commercial success, and navigating the evolving healthcare landscape. There was also a notable departure in the medical leadership.

Departures

Karen L. Smith, M.D., Ph.D., Karen L. Smith, M.D., Ph.D., departed from her role as Chief Medical Officer, having made significant contributions during her tenure.

New Appointments:

Kevin Feeley, Kevin Feeley was confirmed as the permanent Chief Financial Officer after serving in an interim capacity, bringing continuity to financial leadership.
Melanie Photograph, Melanie Photograph was appointed as Chief Operating Officer, bringing extensive experience in scaling operations within diagnostic companies.
Geoff Metcalf, Geoff Metcalf joined GeneDx as Chief Technology Officer to lead the company's technology vision and innovation in genomic data platforms.
Jennifer Brendel, Jennifer Brendel was appointed to the newly created role of Chief Growth Officer to accelerate GeneDx's commercial expansion.
Emily F. Guzzardi, Emily F. Guzzardi was appointed as Chief Counsel, strengthening the executive team with her legal expertise in the healthcare industry.

What Technology (Tech Stack) Is Used byGeneDx?

Discover the tools GeneDx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

GeneDx Email Formats and Examples

GeneDx commonly utilizes standard professional email address formats. The most frequently observed pattern for employee email addresses at GeneDx is 'first.last@genedx.com'. Another potential format, though less common, might be 'firstinitiallast@genedx.com'. Using the primary format is generally the most reliable approach for initial contact.

first.last@genedx.com

Format

jane.doe@genedx.com

Example

85%

Success rate

What's the Latest News About GeneDx?

GeneDx Investor Relations / GlobeNewswireMay 9, 2024

GeneDx Announces First Quarter 2024 Financial Results and Business Updates

GeneDx reported its Q1 2024 financial results, highlighting revenue growth of 26% year-over-year in its core areas, significant progress on its path to profitability, and updates on increasing genomic testing volumes and advancements in its data platform....more

GeneDx Investor Relations / Business WireMarch 14, 2024

GeneDx Showcases Expanded Capabilities of Whole Genome Sequencing and Exome Analysis at the 2024 ACMG Annual Clinical Genetics Meeting

GeneDx presented multiple studies and data at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting, demonstrating advancements in diagnostic yields using whole genome and exome sequencing, particularly for rare pediatric disorders and neurodevelopmental conditions....more

GeneDx Investor Relations / GlobeNewswireFebruary 6, 2024

GeneDx Appoints Jennifer Brendel as Chief Growth Officer

GeneDx announced the appointment of Jennifer Brendel to the newly created role of Chief Growth Officer. Ms. Brendel is tasked with leading the company’s commercial growth strategy and execution to expand market penetration and revenue....more

GeneDx Investor Relations / GlobeNewswireJanuary 3, 2024

GeneDx Appoints Geoff Metcalf as Chief Technology Officer

GeneDx announced the appointment of Geoff Metcalf as Chief Technology Officer, effective January 2, 2024. Mr. Metcalf will lead the company's technology strategy, data science initiatives, and software engineering efforts to further enhance GeneDx's genomic insights platform....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including GeneDx, are just a search away.